Antigens, CD4
- Name
- Antigens, CD4
- Accession Number
- DBCAT001778 (DBCAT005012)
- Description
Not Available
- Drugs
Drug Drug Description Clenoliximab Investigated for use/treatment in rheumatoid arthritis. - Drugs & Drug Targets
Drug Target Type Clenoliximab T-cell surface glycoprotein CD4 target